Indivior PLC Logo

Indivior PLC

Pharmaceutical company developing medicines for substance use and mental disorders.

INDV | IL

Overview

Corporate Details

ISIN(s):
GB00BN4HT335 (+2 more)
LEI:
213800V3NCQTY7IED471
Country:
United Kingdom
Address:
234 BATH ROAD, SL1 4EE SLOUGH

Description

Indivior PLC is a global pharmaceutical company that develops, manufactures, and sells medicines to treat substance use disorders (SUD) and serious mental illnesses. The company's primary focus is on pioneering treatments for opioid use disorder (OUD), with a portfolio centered on buprenorphine-based prescription pharmaceuticals. Through its research and development efforts, Indivior aims to address the complex challenges of addiction and behavioral health by providing innovative, life-transforming therapies for patients worldwide.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-07-24 16:52
Holding(s) in Company
English 23.4 KB
2025-07-24 09:34
Holding(s) in Company
English 25.1 KB
2025-07-23 09:08
Holding(s) in Company
English 25.1 KB
2025-07-21 17:23
Holding(s) in Company
English 25.1 KB
2025-07-21 09:33
Holding(s) in Company
English 25.1 KB
2025-07-18 09:35
Holding(s) in Company
English 25.2 KB
2025-07-17 15:00
Notice of Results
English 10.6 KB
2025-07-01 09:43
Holding(s) in Company
English 56.2 KB
2025-07-01 08:49
Total Voting Rights
English 4.8 KB
2025-06-30 08:00
Indivior Announces Inclusion in US Russell Indexes
English 12.9 KB
2025-06-25 08:00
Indivior Appoints Tony Kingsley to the Board
English 14.0 KB
2025-06-17 17:42
Holding(s) in Company
English 26.7 KB
2025-06-13 09:10
Director/PDMR Shareholding - Correction
English 28.2 KB
2025-06-12 17:24
Director/PDMR Shareholding
English 26.9 KB
2025-06-10 17:12
Holding(s) in Company
English 26.8 KB

Automate Your Workflow. Get a real-time feed of all Indivior PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Indivior PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Indivior PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

AVACTA GROUP PLC Logo
Clinical-stage biotech developing targeted oncology drugs with a proprietary platform.
United Kingdom
AVCT
AVADEL PHARMACEUTICALS PLC Logo
Biopharmaceutical company developing therapies for sleep disorders, focusing on narcolepsy.
United States of America
AVDL
Avalon GloboCare Corp. Logo
Develops cell-based immunotherapies and provides precision diagnostics and lab services.
United States of America
ALBT
Avidity Biosciences, Inc. Logo
Develops a class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs).
United States of America
RNA
Axogen, Inc. Logo
Develops and commercializes surgical solutions for peripheral nerve repair.
United States of America
AXGN
Axsome Therapeutics, Inc. Logo
A biopharmaceutical company developing therapies for central nervous system disorders.
United States of America
AXSM
AYTU BIOPHARMA, INC Logo
A specialty pharma company developing novel therapeutics for complex CNS diseases.
United States of America
AYTU
Azitra, Inc. Logo
Clinical-stage biopharma company developing microbiome-based therapies for skin diseases.
United States of America
AZTR
Bachem Holding AG Logo
A CDMO developing and manufacturing peptides and oligonucleotides for pharma and biotech.
Switzerland
BANB
Barinthus Biotherapeutics plc. Logo
Clinical-stage biopharma developing immunotherapies that guide T cells to control disease.
United States of America
BRNS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.